Relay Therapeutics, Inc.
RLAY
$3.69
$0.288.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.49% | -1.30% | 1.25% | -5.90% | 6.27% |
| Total Depreciation and Amortization | -10.73% | -3.48% | 3.70% | 8.79% | 16.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.00% | -10.39% | -0.48% | 14.59% | 12.78% |
| Change in Net Operating Assets | 18.80% | 73.54% | 145.04% | -35.33% | -224.35% |
| Cash from Operations | 6.88% | 4.06% | 17.05% | -4.56% | -8.41% |
| Capital Expenditure | 74.51% | 84.41% | 51.09% | 66.22% | 68.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -88.88% | -104.33% | -114.92% | -114.42% | 1,192.50% |
| Cash from Investing | -89.07% | -104.74% | -115.95% | -120.39% | 2,634.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 169.24% | 168.56% | 677.35% | 1,980.36% | -71.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 169.24% | 168.56% | 677.35% | 1,980.36% | -71.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -75.20% | -623.57% | -152.71% | 100.22% | -130.75% |